Lifitegrast, sold under the brand name Xiidra (), is a medication for the treatment of signs and symptoms of dry eye, a syndrome called keratoconjunctivitis sicca. Lifitegrast reduces inflammation by inhibiting inflammatory cell binding. It is often used as an alternative to ciclosporin (Ikervis, Restasis, Vevye, Verkazia or Cequa) for dry eye treatment including meibomian gland dysfunction and inflammatory dry eye.
via Wikipedia infobox
{{Infobox drug | image = Lifitegrast skeletal.svg | image_class = skin-invert-image | alt = | caption =
| pronounce = | tradename = Xiidra | Drugs.com = | MedlinePlus = a616039 | pregnancy_AU = B1 | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = Eye drops | ATCvet = | ATC_prefix = S01 | ATC_suffix = XA25
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).